DORCHESTER WEALTH MANAGEMENT Co Sells 2,127 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

DORCHESTER WEALTH MANAGEMENT Co cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 37.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,534 shares of the healthcare conglomerate’s stock after selling 2,127 shares during the quarter. DORCHESTER WEALTH MANAGEMENT Co’s holdings in UnitedHealth Group were worth $2,066,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Capital Insight Partners LLC raised its position in UnitedHealth Group by 3.8% in the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares during the last quarter. Tealwood Asset Management Inc. bought a new position in UnitedHealth Group in the third quarter valued at about $2,905,000. Vantage Investment Partners LLC raised its position in shares of UnitedHealth Group by 42.2% during the first quarter. Vantage Investment Partners LLC now owns 152,107 shares of the healthcare conglomerate’s stock worth $75,247,000 after acquiring an additional 45,173 shares during the last quarter. Sequoia Financial Advisors LLC raised its position in shares of UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after acquiring an additional 3,006 shares during the last quarter. Finally, Maryland State Retirement & Pension System raised its position in shares of UnitedHealth Group by 0.6% during the first quarter. Maryland State Retirement & Pension System now owns 72,689 shares of the healthcare conglomerate’s stock worth $35,126,000 after acquiring an additional 469 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.7 %

Shares of NYSE:UNH opened at $560.82 on Friday. The stock has a market cap of $517.87 billion, a price-to-earnings ratio of 36.54, a PEG ratio of 1.67 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The business’s 50 day moving average is $584.16 and its 200 day moving average is $536.49.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.56 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Bank of America lowered their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their target price for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.